Latest Agonist Stories
Structures of human P2Y12 receptor key to next generation of antithrombotic drugs SHANGHAI, April 30, 2014 /PRNewswire/ -- An international team led by scientists at the Shanghai Institute
Patients that are concerned with uneven eyebrows now have an alternative to surgery – Botox.
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered the mechanism by which a low dose of the opioid antagonist naltrexone (LDN), an agent used clinically (off-label) to treat cancer and autoimmune diseases, exerts a profound inhibitory effect on cell proliferation.
Scientists from The Scripps Research Institute have determined a new structure from a medically important superfamily of proteins.
SAN DIEGO, Dec. 10, 2010 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
MIAMI and EVANSTON, Ill., Dec.
- An armed gangster.